Product
Advertisement
IFN-γ: A Key Player in Cancer Immunity
Interferon gamma (IFN-y) is a cytokine that elicits a cascade of immune responses against viruses and tumors. The binding of IFN-γ at the IFN-γ receptor, which consists of IFNGR1 and IFNGR2, activates pro-apoptotic, anti-tumor, and anti-proliferative functions of the cells. Aberrant expression of IFN-γ promotes tumor development. Hence, IFN-γ has been established as a key player in cancer immunogenicity.
Sino Biological has developed a panel of recombinant IFN-y protein and receptors reagents to support the study of IFN-γ in cancer immunity.
About Sino Biological
Sino Biological is an international reagent supplier and contract research service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced with a stringent quality management system, and include unique bioreagents addressing areas such as cell therapy, stem cell, and infectious disease research. For example, Sino Biological has a wealth of viral antigens (Provir®) and corresponding antibodies, with one of the world’s Extensive collections. Sino Biological is also a well-recognized, qualified source of recombinant cytokines and high-quality GMP-grade cytokines. In addition, Sino Biological offers contract research production services for the custom development of full length, bioactive proteins and high-affinity antibodies, along with other services. To learn more about Sino Biological visit www.sinobiological.com, follow us on LinkedIn or @SinoInc on Twitter.
Interested in seeing more content from Sino Biological?
Discover all their latest news, webinars, products and more by clicking the link below.
